Trinity Biotech plc (NASDAQ:TRIB) Q2 2022 Results Conference Call November 3, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Aris Kekedjian - Chief Executive Officer John Gillard - Chief Financial Officer and Director Conference Call Participants Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Operator Good day, and welcome to the Trinity Biotech Second Quarter Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like ...

Exhibit 99.1 Press Release dated June 30, 2022 Contact:Trinity Biotech plc Lytham Partners, LLC John Gillard Joe Diaz (353)-1-2769800 (1)-602-889-9700 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Quarter 1 2022 Financial Results DUBLIN, Ireland (June 30, 2022)…. Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company's results for the quarter ended March 31, 20 ...

Trinity Biotech plc (NASDAQ:TRIB) Q1 2022 Earnings Conference Call June 30, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Ronan OÂ'Caoimh - Chairman and Chief Executive Officer John Gillard - Chief Financial Officer and Director Conference Call Participants Jim Sidoti - Sidoti & Co Operator Good day, and welcome to the Trinity Biotech First Quarter Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being ...

SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ...

Exhibit 99.1 Press Release dated April 11, 2022 Contact: Trinity Biotech plc Lytham Partners, LLC John Gillard Joe Diaz (353)-1-2769800 (1)-602-889-9700 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results DUBLIN, Ireland (April 11, 2022)…. Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended Decembe ...

Exhibit 99.1 September 30, 2021 Contact: Trinity Biotech plc Lytham Partners, LLC John Gillard Joe Diaz (353)-1-2769800 (1)-602-889-9700 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Results of AGM Dublin, Ireland (September 30, 2021)…. Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results of the Annual General Meeting (AGM). AGM Results On September 29, 2021 Trin ...

Trinity Biotech plc (NASDAQ:TRIB) Q2 2021 Earnings Conference Call September 9, 2021 11:00 AM ET Company Participants Joe Diaz - Lytham Partners Ronan OÂ'Caoimh - Chairman and Chief Executive Officer John Gillard - Chief Financial Officer and Director Conference Call Participants Jim Sidoti - Sidoti & Co Paul Nouri - Noble Equity Funds Operator Good morning, everyone. And welcome to the Trinity Biotech Q2 2021 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instr ...

Trinity Biotech plc (NASDAQ:TRIB) Q1 2021 Results Conference Call May 25, 2021 11:00 AM ET Company Participants Joe Diaz - Lytham Partners Ronan OâCaoimh - CEO John Gillard - CFO Conference Call Participants Paul Nouri - Noble Equity Funds Jim Sidoti - Sidoti & Co Operator Good day, and welcome to the Trinity Biotech First Quarter 2021 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After todayâs presentation, there will be an opportunity to ask que ...

SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ...

Trinity Biotech plc (NASDAQ:TRIB) Q4 2020 Results Conference Call March 26, 2021 11:00 AM ET Company Participants Ronan O’Caoimh - CEO John Gillard - CFO Conference Call Participants Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the Trinity Biotech Q4 and Fiscal Year 2020 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator instructions] Please note, th ...